Disability News and Research

RSS

U of M's 'Ask About Aspirin' initiative aims to reduce incidence of first heart attack or stroke

Cardiovascular diseases are the leading causes of death and disability in the United States, accounting for nearly one-third of all deaths. The diseases also create an immense national health economic burden.

30 Jan 2016

Fingolimod trial INFORMS primary progressive MS strategy

Fingolimod is unable to slow disability progression or brain volume loss in patients with primary progressive multiple sclerosis, show the findings of the INFORMS study.

29 Jan 2016

Clinicoradiological syndromes allow rapid recognition of EV71 neurological problems

Severe enterovirus 71 neurological disease in children predominantly involves the spinal cord and brainstem and can be quickly recognised using the World Health Organisation classification of clinicoradiological syndromes, study findings suggest.

29 Jan 2016

Dysport phase III study results in children with cerebral palsy with lower limb spasticity published in Pediatrics

Ipsen today announced that the scientific journal Pediatrics published the detailed results of the phase III randomized study showing both the efficacy and the safety of Dysport in the treatment of dynamic equinus foot deformity, a condition associated with cerebral palsy in children.

28 Jan 2016

New findings offer roadmap for development of novel therapies to target common brain disorders

Scientists have pinpointed the cells that are likely to trigger common brain disorders, including Alzheimer's disease, Multiple Sclerosis and intellectual disabilities.

28 Jan 2016

CosmosID announces $6M in Series B funding round

CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-generation DNA sequencing, announced $6M in Series B funding.

28 Jan 2016

Opioid medication does not improve physical function in patients with neuropathic pain

Opioids such as morphine, codeine and Tylenol 3 can be effective for treating pain, however, a new University of Alberta study finds that patients with neuropathic pain taking opioids report no improvements in physical functioning compared to those who were not prescribed opioids.

25 Jan 2016

Twice-daily stimulation of vagus nerve with gammaCore nVNS device reduces number of migraine attacks

A study published in the Journal of Headache and Pain, carried out by Dr. Thomas Kinfe of the University of Bonn, found that twice daily stimulation of the vagus nerve with the hand-held gammaCore nVNS device reduced the number of headache days per month from 14.7 to 8.9 (p<0.001) and the number of monthly migraine attacks from 7.3 to 4.5 (p<0.001).

21 Jan 2016

Concussions related to sports and recreation activities affect millions of Americans

Every year, between 3 million and 4 million Americans suffer concussions in sports and recreation. Head impacts and concussions caused by contact sports are a quickly growing epidemic among young athletes.

19 Jan 2016

Wearing helmet could cut life-threatening sledding injuries in kids

With the coldest months of the year upon us, it’s only a matter of time until the first snowfall of the season hits. Sledding, a seasonal favorite for children of all ages seeking thrills, is probably high on kids’ to-do lists as the first flakes hit the ground.

18 Jan 2016

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Novartis announced today that the US Food and Drug Administration has approved Cosentyx (secukinumab) for two new indications - the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).

17 Jan 2016

First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR).

13 Jan 2016

Liazon named winner of Fall 2015 Digital Health Awards

Liazon, operator of the industry-leading private benefits exchange for businesses across the U.S., was named a winner of the Fall 2015 Digital Health Awards. Liazon's flagship product, the Bright Choices Exchange, received an award in the "Portal" category, making this the fourth consecutive Digital Health Award the exchange has received.

12 Jan 2016

Johns Hopkins researchers show that stroke may increase brain plasticity, recovery in some cases

Using mice whose front paws were still partly disabled after an initial induced stroke, Johns Hopkins researchers report that inducing a second stroke nearby in their brains let them “rehab” the animals to successfully grab food pellets with those paws at pre-stroke efficiency.

8 Jan 2016

Muscle exercise can help reduce pain, disability caused by lower back pain

A new Cochrane Review published today shows that targeting exercises to muscles that support and control the spine offers another strategy to reduce pain and disability caused by lower back pain.

8 Jan 2016

AngioDefender holds much promise for personalized cardiac care

For a non-descript box it wields a mighty name and even more impressive possibilities for people with heart disease. Called the AngioDefender, the machine - no bigger than a shoebox - holds much promise in the ability to personalize cardiac care, say researchers at Lawson Health Research Institute, the research arm of St. Joseph's Health Care London.

8 Jan 2016

Oxygen sensor PHD1 identified as potential target for treatment of ischemic stroke

Scientists at VIB and KU Leuven have identified the oxygen sensor PHD1 as a potential target for the treatment of brain infarction (ischemic stroke). Despite (minor) improvements in stroke treatment, stroke remains the fourth leading cause of death and the most common reason of severe disability.

8 Jan 2016

Study highlights impact of health and safety programs on companies' investment value

A study utilizing investment simulations for 17 publicly held companies with strong health or safety programs for employees suggests that employers that invest significantly in health and safety programming can outperform other companies in the marketplace.

7 Jan 2016

$Major bone fracture may increase risk of widespread chronic body pain in later life$

Major bone fracture may increase risk of widespread chronic body pain in later life

Breaking a major bone may increase risk of widespread chronic body pain in later life, a new study has found.

6 Jan 2016

Researchers identify factors that may predict outcomes in pediatric patients with intracranial GSWs

Researchers from Memphis, Tennessee, have examined intracranial gunshot wounds (GSWs) in children and adolescents, and identified nine clinical, laboratory, and radiological factors that were predictive of these patients' outcomes.

5 Jan 2016

Disability News and Research

U of M's 'Ask About Aspirin' initiative aims to reduce incidence of first heart attack or stroke

Fingolimod trial INFORMS primary progressive MS strategy

Clinicoradiological syndromes allow rapid recognition of EV71 neurological problems

Dysport phase III study results in children with cerebral palsy with lower limb spasticity published in Pediatrics

New findings offer roadmap for development of novel therapies to target common brain disorders

CosmosID announces $6M in Series B funding round

Opioid medication does not improve physical function in patients with neuropathic pain

Twice-daily stimulation of vagus nerve with gammaCore nVNS device reduces number of migraine attacks

Concussions related to sports and recreation activities affect millions of Americans

Wearing helmet could cut life-threatening sledding injuries in kids

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

Liazon named winner of Fall 2015 Digital Health Awards

Johns Hopkins researchers show that stroke may increase brain plasticity, recovery in some cases

Muscle exercise can help reduce pain, disability caused by lower back pain

AngioDefender holds much promise for personalized cardiac care

Oxygen sensor PHD1 identified as potential target for treatment of ischemic stroke

Study highlights impact of health and safety programs on companies' investment value

Major bone fracture may increase risk of widespread chronic body pain in later life

Researchers identify factors that may predict outcomes in pediatric patients with intracranial GSWs

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News